Identification of Host and Viral Determinants of Human Norovirus B cell Infection

人诺如病毒 B 细胞感染的宿主和病毒决定因素的鉴定

基本信息

  • 批准号:
    10062847
  • 负责人:
  • 金额:
    $ 47.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-01 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

SUMMARY Human noroviruses are a leading global cause of severe childhood diarrhea and gastroenteritis outbreaks. However, development of therapeutic and preventative strategies has been severely limited by the inability to propagate these viruses in culture. We recently discovered that noroviruses infect B cells in vitro and in vivo, and that they utilize commensal bacteria as a co-factor for infection. These novel findings led directly to our development of the first human norovirus cultivation system, a tool that will revolutionize norovirus research. We are now uniquely poised to identify host restriction and susceptibility factors influencing human norovirus infection of B cells as well as viral determinants of B cell infection. We hypothesize that this information will reveal key virus-host interactions that can guide the development of novel therapeutics, vaccine candidates, and enhanced diagnostic strategies. In Specific Aim 1, we will utilize complementary targeted and unbiased approaches to develop a comprehensive set of host factors that either restrict or promote human norovirus infection of B cells. In Specific Aim 2, a multi-pronged approach will be undertaken to identify viral determinants of in vitro replicative fitness. Strategies include serial passaging of virus in permissive cells and testing a diverse set of human norovirus genotypes for B cell infectivity. We will also construct a human norovirus reverse genetics system to test adaptive mutations for phenotypic effects. These studies will not only provide critical insight into host and viral determinants of B cell infection by human noroviruses but they should also culminate in the development of 2nd generation culture systems supporting robust infection of a broad panel of viral genotypes.
总结

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The major targets of acute norovirus infection are immune cells in the gut-associated lymphoid tissue.
  • DOI:
    10.1038/s41564-017-0057-7
  • 发表时间:
    2017-12
  • 期刊:
  • 影响因子:
    28.3
  • 作者:
    Grau KR;Roth AN;Zhu S;Hernandez A;Colliou N;DiVita BB;Philip DT;Riffe C;Giasson B;Wallet SM;Mohamadzadeh M;Karst SM
  • 通讯作者:
    Karst SM
Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.
  • DOI:
    10.1186/s13073-022-01013-1
  • 发表时间:
    2022-01-27
  • 期刊:
  • 影响因子:
    12.3
  • 作者:
    Grodzki M;Bluhm AP;Schaefer M;Tagmount A;Russo M;Sobh A;Rafiee R;Vulpe CD;Karst SM;Norris MH
  • 通讯作者:
    Norris MH
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephanie M Karst其他文献

Stephanie M Karst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephanie M Karst', 18)}}的其他基金

Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
阐明诺如病毒腹泻的致病机制
  • 批准号:
    10624395
  • 财政年份:
    2021
  • 资助金额:
    $ 47.78万
  • 项目类别:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
阐明诺如病毒腹泻的致病机制
  • 批准号:
    10413248
  • 财政年份:
    2021
  • 资助金额:
    $ 47.78万
  • 项目类别:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
阐明诺如病毒腹泻的致病机制
  • 批准号:
    10277083
  • 财政年份:
    2021
  • 资助金额:
    $ 47.78万
  • 项目类别:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
通过微生物群调节的胆汁酸抑制肠道诺如病毒感染
  • 批准号:
    10061535
  • 财政年份:
    2018
  • 资助金额:
    $ 47.78万
  • 项目类别:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
通过微生物群调节的胆汁酸抑制肠道诺如病毒感染
  • 批准号:
    10517512
  • 财政年份:
    2018
  • 资助金额:
    $ 47.78万
  • 项目类别:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
通过微生物群调节的胆汁酸抑制肠道诺如病毒感染
  • 批准号:
    10289716
  • 财政年份:
    2018
  • 资助金额:
    $ 47.78万
  • 项目类别:
Role of Intestinal Bacteria in Human Norovirus Infection
肠道细菌在人类诺如病毒感染中的作用
  • 批准号:
    9208092
  • 财政年份:
    2015
  • 资助金额:
    $ 47.78万
  • 项目类别:
Role of Intestinal Bacteria in Human Norovirus Infection
肠道细菌在人类诺如病毒感染中的作用
  • 批准号:
    9416071
  • 财政年份:
    2015
  • 资助金额:
    $ 47.78万
  • 项目类别:
Role of Intestinal Bacteria in Human Norovirus Infection
肠道细菌在人类诺如病毒感染中的作用
  • 批准号:
    8863018
  • 财政年份:
    2015
  • 资助金额:
    $ 47.78万
  • 项目类别:
Lack of protective immunity to murine norovirus infection
缺乏对鼠诺如病毒感染的保护性免疫力
  • 批准号:
    8263416
  • 财政年份:
    2010
  • 资助金额:
    $ 47.78万
  • 项目类别:

相似海外基金

Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.78万
  • 项目类别:
    Research Grant
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 47.78万
  • 项目类别:
    Research Grant
Rational Design of live-attenuated vaccines for flaviviruses
黄病毒减毒活疫苗的合理设计
  • 批准号:
    10397675
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
  • 批准号:
    10027464
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
  • 批准号:
    10405637
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
  • 批准号:
    10188419
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
Rapid generation and testing of live-attenuated vaccines against SARS-CoV-2
快速生成和测试 SARS-CoV-2 减毒活疫苗
  • 批准号:
    10184147
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
  • 批准号:
    10674134
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
  • 批准号:
    10636632
  • 财政年份:
    2020
  • 资助金额:
    $ 47.78万
  • 项目类别:
Live attenuated vaccines to prevent against disease caused by A. pleuropneumoniae
用于预防胸膜肺炎放线杆菌引起的疾病的减毒活疫苗
  • 批准号:
    BB/S000321/1
  • 财政年份:
    2018
  • 资助金额:
    $ 47.78万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了